Abstract:BACKGROUND & OBJECTIVEChemokines are small molecule proteins that are the main mediators of cell migration. Studies indicated that chemokines could induce antitumor immune response strongly and steadily. At present, there was not antitumor therapy about chemokine BLC combined with chemotherapy. This study was designed to explore the anti-tumor effects and mechanisms of BLC-modified tumor cell vaccine combined with cisplatin.METHODSFirstly, we transfected pcDNA-BLC into murine tumor cell lines and established stable transfected tumor cell lines (Colon26 and LL/2) to express BLC. Null plasmid pcDNA3.1 (+) was also transfected into Colon 26 or LL/2 cells stably for comparison. We established mouse model with pcDNA-BLC stable transfected tumor cells (Tc), control mouse model with pcDNA3.1(+) stable transfected tumor cells (Pc), and mouse model with parental tumor cells (Nc). Then the 60 mice were inoculated subcutaneously (s.c.) in the right flanks with a total of 5x10(5) viable tumor cells (Tc to 20 mice, Pc to 20 mice, and Nc to 20 mice, respectively; 6-8 week BALB/c female mouse in colon 26 mouse model or 6-8 week C57BL/6 female mouse in LL/2 mouse model). The groups (Tc, Pc, and Nc) were randomly subdivided into Group A and Group B with 10 mice for each, resulting in Tc-A/Tc-B, Pc-A/Pc-B, and Nc-A/Nc-B, respectively. Group A (including Tc-A, Pc-A, and Nc-A) as chemotherapy group was injected (i.p.) with 0.1 ml cisplatin at the concentration of 2 mg/kg once a week for two weeks; Group B (including Tc-B, Pc-B, and Nc-B) as control with 0.1 normal saline. We further observed anti-tumor activity including the tumor growth, mice survival rate, side effects as well as tumor morphological analysis. Apoptotic cells were also determined in tumor tissues.RESULTSThe combination therapy group Tc-A showed significant anticancer activities. The tumor growth was inhibited efficiently with 3/10 mice showing complete regression in LL/2 mouse model and 1/10 mice showing complete regression in Colon 26 mouse model. The combination therapy group Tc-A showed that the survival rate of mice was 100% in the two mouse models, compared with 68% in group Tc-B in C57BL/6 mouse model and 65% in group Tc-B in Colon 26 mouse model and those in other groups. In addition, the combination therapy group Tc-A induced tumor cell apoptosis significantly.CONCLUSIONSThe therapy of BLC-modified tumor cell vaccine combined with cisplatin had significant synergistic effect against tumor. It might develop a new approach for specific immunotherapy of tumors.

Studies of the Anticancer Effect of Calcineurin B

Effect of the Calcineurin on Immune Reconstitution Inflammatory Syndrome in AIDS

RCAN1-mediated Calcineurin Inhibition As a Target for Cancer Therapy

Cellular And Molecular Consequences Of Calcineurin A Alpha Gene Deletion

Overexpression Of Calcineurin B Subunit (Cnb) Enhances The Oncogenic Potential Of Hek293 Cells

Inhibitive effect of Clinacanthus nutans (Burm.f.) Lindau n-butanol extracts on Heps hepatoma in mice

Expression of Calcineurin Signaling Pathway in Tumorigenesis of Colorectal Carcinoma

[Experimental Studies on Anti-Tumor Effects of BLC-modified Tumor Cell Vaccine Combined with Cisplatin].

The studies of chlorogenic Acid antitumor mechanism by gene chip detection: the immune pathway gene expression

Three‐Pronged Induction of Tumor Calcification Synergistic Calcium Immunotherapy Enables Diagnosis and Cure of Cancer

Calcineurin B1 subunit in human peripheral blood mononuclear cells and its role in idiopathic membranous nephropathy

Evaluation of Anti-Cancer Potency of Silibinin on Murine Renal Carcinoma RenCa Cells in an Animal Model with an Intact Immune System

Calcineurin inactivation inhibits pyruvate dehydrogenase complex activity and induces the Warburg effect

C-type natriuretic peptide (CNP) inhibits 7,12-Dimethylbenz[a]anthracene (DMBA)/Croton oil-induced skin tumor growth by modulating inflammation in Swiss albino mice

rhCNB Improves Cyclophosphamide-Induced Immunodeficiency in BALB/c Mice

Chp2 Activates the Calcineurin/Nuclear Factor of Activated T Cells Signaling Pathway and Enhances the Oncogenic Potential of Hek293 Cells

The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis

Casticin Promotes Immune Responses, Enhances Macrophage and NK Cell Activities, and Increases Survival Rates of Leukemia BALB/c Mice.

Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic renal cell carcinoma by decreasing IL-6 to modulate tumor-associated macrophage and myeloid-derived suppressor cell.

Effect on Xenograft of Nude Mouse by Combination Therapy of Nm23-H1 and Protein-cisplatin

Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D